Amedeo Smart

Free Medical Literature Service


 

Amedeo

Cytomegalovirus Infection

  Free Subscription

Articles published in
Transplantation
    January 2024
  1. ROBERTS MB, Kotton CN
    Conversion to mTOR Inhibitor to Reduce the Incidence of Cytomegalovirus Recurrence in Kidney Transplant Recipients Receiving Preemptive Treatment: A Prospective, Randomized Trial.
    Transplantation. 2024 Jan 26. doi: 10.1097/TP.0000000000004908.
    >> Share

  2. ROBERTS MB, Kotton CN
    Letermovir Prophylaxis After Kidney Transplantation: Another Tool but Not a Revolution Yet.
    Transplantation. 2024;108:7-9.
    >> Share

    December 2023
  3. QIU Y, Zhang Y, Teng M, Cheng S, et al
    Efficacy, Safety, and Cost-effectiveness Analysis of Antiviral Agents for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
    Transplantation. 2023 Dec 5. doi: 10.1097/TP.0000000000004856.
    >> Share

    November 2023
  4. REUSING JO JR, Agena F, Kotton CN, Campana G, et al
    QuantiFERON-CMV as a Predictor of CMV Events During Preemptive Therapy in CMV-seropositive Kidney Transplant Recipients.
    Transplantation. 2023 Nov 22. doi: 10.1097/TP.0000000000004870.
    >> Share

    October 2023
  5. STEWART AG, Kotton CN
    What's New: Updates on Cytomegalovirus in Solid Organ Transplantation.
    Transplantation. 2023 Oct 30. doi: 10.1097/TP.0000000000004855.
    >> Share

    August 2023
  6. TONIATO DE REZENDE FRESCHI J, Cristelli MP, Viana LA, Ficher KN, et al
    A Head-to-head Comparison of De Novo Sirolimus or Everolimus Plus Reduced-dose Tacrolimus in Kidney Transplant Recipients: A Prospective and Randomized Trial.
    Transplantation. 2023 Aug 1. doi: 10.1097/TP.0000000000004749.
    >> Share

    May 2023
  7. BLOM KB, Birkeland GK, Midtvedt K, Jenssen TG, et al
    Cytomegalovirus High-risk Kidney Transplant Recipients Show No Difference in Long-term Outcomes Following Preemptive Versus Prophylactic Management.
    Transplantation. 2023 May 26. doi: 10.1097/TP.0000000000004615.
    >> Share

  8. KOTTON CN
    The Best Method for CMV Prevention in High-risk Kidney Transplant Recipients? Either, per National Norwegian Transplant Database: Commentary on Blom et al, Cytomegalovirus High-risk Kidney Transplant Recipients Show No Difference in Long-term Outcomes
    Transplantation. 2023 May 22. doi: 10.1097/TP.0000000000004616.
    >> Share

    April 2023
  9. VIANA LA, Cristelli MP, Basso G, Santos DW, et al
    Conversion to mTOR Inhibitor to Reduce the Incidence of Cytomegalovirus Recurrence in Kidney Transplant Recipients Receiving Preemptive Treatment: A Prospective, Randomized Trial.
    Transplantation. 2023 Apr 13. doi: 10.1097/TP.0000000000004559.
    >> Share

  10. PIERROTTI LC, Clemente WT
    New Perspectives in Cytomegalovirus After Transplant: The Role of Immunosuppressant Management.
    Transplantation. 2023 Apr 13. doi: 10.1097/TP.0000000000004560.
    >> Share

    March 2023
  11. MOSSAD SB
    Changes in Donor and Recipient Demographic Characteristics Over Time Explain the Increasing Prevalence of the High-risk Cytomegalovirus Donor-positive/Recipient-negative Serostatus in Solid Organ Transplant Recipients.
    Transplantation. 2023;107:e82.
    >> Share

  12. HIGDON LE, Tan JC, Maltzman JS
    Infection, Rejection, and the Connection.
    Transplantation. 2023;107:584-595.
    >> Share

    October 2022
  13. SCHOEBERL AK, Zuckermann A, Kaider A, Aliabadi-Zuckermann A, et al
    Absolute Lymphocyte Count as a Marker for Cytomegalovirus Infection After Heart Transplantation.
    Transplantation. 2022 Oct 13. pii: 00007890-990000000-00197.
    >> Share

    September 2022
  14. IMLAY H, Wagener MM, Vutien P, Perkins J, et al
    Increasing Proportion of High-risk Cytomegalovirus Donor-Positive/Recipient-Negative Serostatus in Solid Organ Transplant Recipients.
    Transplantation. 2022 Sep 29. pii: 00007890-990000000-00175.
    >> Share

    June 2022

  15. Cytomegalovirus Infection Downregulates Vitamin D Receptor in Patients Undergoing Hematopoietic Stem Cell Transplantation: Erratum.
    Transplantation. 2022;106:e324.
    >> Share

    April 2022
  16. KAUKE-NAVARRO M, Panayi AC, Formica R, Marty F, et al
    Cytomegalovirus-related Complications and Management in Facial Vascularized Composite Allotransplantation: An International Multicenter Retrospective Cohort Study.
    Transplantation. 2022 Apr 6. pii: 00007890-990000000-00012.
    >> Share

    March 2022
  17. PEGHIN M, Hirsch HH
    CARVs, CLAD and CMV: A Call for Heightened Awareness in Lung Transplant Recipients.
    Transplantation. 2022 Mar 18. pii: 00007890-900000000-95049.
    >> Share

    September 2021
  18. HEIM C, Muller PP, Tandler R, Cherikh WS, et al
    Cytomegalovirus Donor Seropositivity Negatively Affects Survival After Heart Transplantation.
    Transplantation. 2021 Sep 23. pii: 00007890-900000000-95151.
    >> Share

    July 2021
  19. AXELROD D, Chang SH, Lentine KL, Schnitzler MA, et al
    The Clinical and Economic Benefit of CMV Matching in Kidney Transplant: A Decision Analysis.
    Transplantation. 2021 Jul 6. pii: 00007890-900000000-95204.
    >> Share

  20. L S, I A, N R, J W, et al
    P-74: Change in CMV Infection Rates Over Time at a UK Transplant Centre.
    Transplantation. 2021;105.
    >> Share

    June 2021
  21. LIU XB, Liu H, Liu J, Cheung AKL, et al
    Cytomegalovirus Latency Exacerbated small-for-size Liver Graft Injury through Activation of CCL19/CCR7 in Hepatic Stellate Cells.
    Transplantation. 2021 Jun 2. doi: 10.1097/TP.0000000000003846.
    >> Share

    March 2021
  22. DAVID E, Zhu M, Bennett BC, Cheng D, et al
    Undernutrition and Hypoleptinemia Modulate Alloimmunity and CMV-specific Viral Immunity in Transplantation.
    Transplantation. 2021 Mar 10. pii: 00007890-900000000-95315.
    >> Share

    December 2020
  23. SINGH N, Winston DJ, Razonable RR, Lyon GM, et al
    Association of HHV-6 With Outcomes in CMV-Seronegative Liver Transplant Recipients With CMV-Seropositive Donors Receiving Preemptive Antiviral Therapy.
    Transplantation. 2020 Dec 29. pii: 00007890-900000000-95428.
    >> Share

    November 2020
  24. COOK CH
    Cytomegalovirus: Another Source of Antibody Mediated Graft Injury?
    Transplantation. 2020 Nov 18. doi: 10.1097/TP.0000000000003549.
    >> Share

  25. SAUNDERS U, Li M, Boddeda SR, Maher S, et al
    Murine Cytomegalovirus-Induced Complement-fixing Antibodies Deposit in Murine Renal Allografts During Acute Rejection.
    Transplantation. 2020 Nov 18. doi: 10.1097/TP.0000000000003548.
    >> Share

    February 2020
  26. KOTTON CN
    A Fine Balance: Using Letermovir for Salvage Antiviral Treatment While Preserving Efficacy.
    Transplantation. 2020;104:240-241.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016